Biological E Limited on Saturday announced that its COVID-19 vaccine Corbevax has been approved by the Drug Controller General of India as a heterologous booster dose. A press release from the......
The government on Wednesday approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin. IMAGE: A healthcare worker inoculates......
India has covered enough population with vaccine and infection, but protein vaccines should remain available on payment basis for elderly and those with comorbidities. IMAGE: A healthcare worker......
India's drug regulator has granted restricted emergency use authorisation for Biological E's COVID-19 vaccine Corbevax for those aged five to 12 years and Bharat Biotech's Covaxin for children in......
Biological E Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022 which......
SBI was the top loser in the Sensex pack, shedding over 1 per cent. ITC, NTPC, Tech Mahindra, Tata Steel, Kotak Bank and M&M were among major losers. Benchmark indices Sensex and Nifty retreated......
As many as 28 of its constituents closed with gains while two declined. The broad-based Nifty of the National Stock Exchange rose by 147.20 points or 0.86 per cent to settle 17,233.45, tracking......